SCHERING-PLOUGH CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C07K PEPTIDES 2134
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8187630 Extended release oral dosage compositionOct 02, 09May 29, 12[A61K]
7816118 sp. and uses thereofMay 29, 07Oct 19, 10[C12P, C12N]
7803828 Functionally selective alpha2C adrenoreceptor agonistsAug 23, 06Sep 28, 10[A01N, C07D]
7728165 )-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereofJun 15, 09Jun 01, 10[C07C]
7652003 Macrocyclic β-secretase inhibitorsJul 26, 05Jan 26, 10[A61K, A01N, C07D]
7250286 Methods for the in vitro culture of Sporozoea sp. and uses thereofMay 20, 03Jul 31, 07[C12P]
6505126 Method to identify fungal genes useful as antifungal targetsMar 25, 99Jan 07, 03[C07H, C12Q, C12N, G01N]
6277959 Isolated mammalian membrane protein genes; related reagentsJul 08, 98Aug 21, 01[A61K, C07H, C12P, C07K]
5874442 Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseDec 12, 96Feb 23, 99[A61K, C07D]
5767115 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agentsMar 18, 96Jun 16, 98[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2011/0245,267 PIPERIDINE AND PIPERAZINE DERIVATIVES AND METHODS OF USE THEREOFAbandonedDec 18, 09Oct 06, 11[A61K, C07D, A61P]
2011/0034,478 Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAsAbandonedApr 15, 09Feb 10, 11[A61K, A61P]
7884080 Azetidinone derivatives and methods of use thereofExpiredSep 13, 07Feb 08, 11[A61K, C07D, A61P]
7846946 antagonistsExpiredJul 22, 09Dec 07, 10[A61K, C07D]
7737284 Synthesis of temozolomide and analogsExpiredSep 26, 08Jun 15, 10[C07D, C07C]
2010/0113,821 PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDEAbandonedDec 17, 07May 06, 10[C07C]
2009/0105,282 METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACT SYMPTOMS BY USING PDE 5 INHIBITORSAbandonedDec 17, 08Apr 23, 09[A61K, A61P]
7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virusExpiredAug 24, 04Nov 11, 08[A61K]
2008/0261,289 COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONSAbandonedJun 26, 08Oct 23, 08[C12N]
2007/0004,745 Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using PDE 5 inhibitorsAbandonedMar 23, 06Jan 04, 07[A61K]
6924270 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionExpiredApr 18, 01Aug 02, 05[A61K, A01N]
6812004 Mammalian dendritic cell chemokine reagentsExpiredFeb 10, 97Nov 02, 04[C12N, C07K]
2004/0171,614 Novel gamma secretase inhibitorsAbandonedSep 16, 03Sep 02, 04[A61K, C07D]
2004/0067,950 High affinity ligands for nociceptin receptor ORL-1AbandonedJun 17, 03Apr 08, 04[A61K, C07D]
6667319 Neuropeptide Y Y5 receptor antagonistsExpiredJul 24, 02Dec 23, 03[A61K, C07D]
6645491 Method for treating inflammatory conditions using an antibody to MIP-3.alpha.ExpiredFeb 02, 00Nov 11, 03[A61K]
2003/0170,216 SYN3 compositions and methodsAbandonedDec 20, 02Sep 11, 03[A61K]
6569872 Use of neurokinin receptor antagonists to treat androgen-dependent diseasesExpiredMay 07, 02May 27, 03[A61K]
6528523 Farnesyl protein transferase inhibitorsExpiredNov 27, 01Mar 04, 03[A61K, C07D, A61P]
6361939 Isolated mammalian dendritic cell genes; related reagentsExpiredNov 25, 97Mar 26, 02[C07H, C12Q, C12P, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.